{"url_path":"/sec/coag/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-234386-index.html","accession_number":"0001193125-26-234386","cik":"0002114044","ticker":"COAG","issuer_name":"Hemab Therapeutics Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-234386-index.html","primary_entity_key":"0002114044","primary_entity_name":"Hemab Therapeutics Holdings, Inc."},"word_count":33,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings.\n\nFrom time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not currently subject to any material legal proceedings."}